These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
704 related items for PubMed ID: 22928729
1. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Inch J, Watson MC, Anakwe-Umeh S. Drug Saf; 2012 Oct 01; 35(10):807-18. PubMed ID: 22928729 [Abstract] [Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, Hazell L, Krska J, Lee AJ, McLernon DJ, Murphy E, Shakir S, Watson MC. Health Technol Assess; 2011 May 01; 15(20):1-234, iii-iv. PubMed ID: 21545758 [Abstract] [Full Text] [Related]
11. The value of patient reporting to the pharmacovigilance system: a systematic review. Inácio P, Cavaco A, Airaksinen M. Br J Clin Pharmacol; 2017 Feb 01; 83(2):227-246. PubMed ID: 27558545 [Abstract] [Full Text] [Related]
12. An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta. Curtolo E, Micallef B, Szijj JV, Serracino-Inglott A, Borg JJ. Int J Risk Saf Med; 2024 Feb 01; 35(3):271-286. PubMed ID: 38820023 [Abstract] [Full Text] [Related]
14. Patient Reporting in the EU: Analysis of EudraVigilance Data. Banovac M, Candore G, Slattery J, Houÿez F, Haerry D, Genov G, Arlett P. Drug Saf; 2017 Jul 01; 40(7):629-645. PubMed ID: 28417320 [Abstract] [Full Text] [Related]
15. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre. Nicol C, Moulis F, Bondon-Guitton E, Durrieu G, Montastruc JL, Bagheri H. Therapie; 2019 Oct 01; 74(5):521-525. PubMed ID: 31029402 [Abstract] [Full Text] [Related]
20. Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK. de Vries ST, Denig P, Andrić A, Dimov Di Giusti M, Ptaszynska-Neophytou A, Härmark L, Mol PGM, IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 4. Drug Saf; 2021 Oct 01; 44(10):1073-1083. PubMed ID: 34368940 [Abstract] [Full Text] [Related] Page: [Next] [New Search]